US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

240.53

+3.081.30%

Post-market: 240.540.0084+0.00%16:15 EDT

Volume:9K

Turnover:2.23M

Market Cap:482.63M

PE:- -

High:240.71

Open:236.99

Low:236.64

Close:237.45

52wk High:246.55

52wk Low:171.63

Shares:2.01M

Float Shares:2.01M

Volume Ratio:0.84

T/O Rate:0.47%

Dividend:0.95

Dividend Rate:0.39%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Atricure (ATRC) and Stryker (SYK)

Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing

Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock

Gilead - Expands Six Royalty-Free Voluntary Licensing Agreements for Once-Yearly Lenacapavir for Hiv Prevention

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)

The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.

Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug

Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers

Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar

Revolution Medicines gets orphan designation for pancreatic cancer treatment

Gilead Sciences Expands Lenacapavir Access to 14 Countries

MT Newswires Live

Gilead announces agreement with PAHO for lenacapavir access

Gilead: Explores Opportunities with Brazilian Health Ministry to Advance Ministry’s Goal of Enabling Local Production of Lenacapavir

THOMSON REUTERS

Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds

THOMSON REUTERS

Gilead: Co & Paho Announce Partnership to Accelerate Access to Twice-Yearly Lenacapavir for Hiv Prevention Across Latin America & Caribbean

THOMSON REUTERS

Gilead, PAHO Agree on HIV Prevention Drug Access in Latin America, Caribbean

Gilead: to Continue Exploring Opportunities to Work with Paho to Support Country Readiness & Scale-up of Long-Acting Hiv Prevention Access

THOMSON REUTERS

Gilead Exec Says Weekly Oral Hiv Prevention Drug Expected to Launch in First Quarter of 2027 - Conf Call

THOMSON REUTERS

Gilead Exec Says Hiv Market Growth Should Normalize to 2%-3% Within Next Couple of Quarters - Conf Call

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BBH/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":240.5316,"timestamp":1791230400000,"preClose":237.4531,"halted":0,"volume":9367,"hourTrading":{"tag":"盘后","latestPrice":240.54,"preClose":240.5316,"latestTime":"16:15 EDT","volume":25,"amount":6013.39075,"timestamp":1791231300358,"change":0.0084,"changeRate":0.000035,"amplitude":0.000035},"delay":0,"changeRate":0.012964665443407524,"floatShares":2006503,"shares":2006503,"eps":0,"marketStatus":"Post-Mkt","change":3.0785,"latestTime":"10-05 17:18:58 EDT","open":236.99,"high":240.705,"low":236.6444,"amount":2232355,"amplitude":0.017101,"askPrice":326.44,"askSize":100,"bidPrice":186.37,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791244800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":237.4531,"sharesOutstanding":1976503,"nav":237.39591,"aum":476335613.78,"dividendRate":0.003949,"bidAskSpread":0.001118,"postHourTrading":{"tag":"盘后","latestPrice":240.54,"preClose":240.5316,"latestTime":"16:15 EDT","volume":25,"amount":6013.39075,"timestamp":1791231300358,"change":0.0084,"changeRate":0.000035,"amplitude":0.000035},"volumeRatio":0.838,"impliedVol":0.2044,"impliedVolPercentile":0.6454},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":2006503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.838,"shares":2006503,"dividePrice":0.9498,"high":240.705,"amplitude":0.017101,"preClose":237.4531,"low":236.6444,"week52Low":171.63,"pbRate":"--","week52High":246.55,"institutionHeld":0,"latestPrice":240.5316,"eps":0,"divideRate":0.003949,"volume":9367,"delay":0,"ttmEps":0,"open":236.99,"prevYearClose":189.2649,"prevWeekClose":237.4531,"prevMonthClose":244.575,"prevQuarterClose":244.575,"fiveDayClose":245.3373,"twentyDayClose":241.1222,"sixtyDayClose":205.546},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668962770","title":"Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668962770","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668962770?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:40","pubTimestamp":1789648810,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Charles River Labs (CRL) and Amgen (AMGN) with bulli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-charles-river-labs-crl-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-charles-river-labs-crl-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","LU0868494617.USD","LU0058720904.USD","BK4139","IE00B2B36J28.USD","BK4585","LU1057294990.SGD","IE00BFMHRM44.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU1815336091.USD","BK4599","BK4581","LU1983299246.USD","LU0757428866.USD","AMGN","SG9999001440.SGD","BK4588","IE0002141913.USD","LU0390134368.USD","BK4530","LU1061106388.HKD","LU2468319806.SGD","TBXU","LU0029874061.USD","BK4533","HCSG","LABU","BK4121","LU2112291526.USD","LU2089984988.USD","PJP","BIB","IBB","IE00BJT1NW94.SGD","LU2242646821.SGD","LU0122379950.USD","BK4137","BK4566","IBBQ","LU0128526141.USD","IE0009355771.USD","LU0289739699.SGD","CRL","XLV","XBI","LU0889565916.HKD","PBE","IE00BJJMRZ35.SGD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668961345","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Atricure (ATRC) and Stryker (SYK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668961345","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668961345?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:10","pubTimestamp":1789643407,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amgen (AMGN), Atricure (ATRC) and Stryker (SYK) with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-atricure-atrc-and-stryker-syk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-atricure-atrc-and-stryker-syk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","IBB","SYK","GB00B4LPDJ14.GBP","LU2242652126.USD","LU1571399168.USD","PBE","LABU","LU2404859741.USD","LU2468319806.SGD","PJP","LU0690374615.EUR","BK4581","LU0058720904.USD","ATRC","LU0882574055.USD","BBH","LU0690374961.EUR","LU0432979614.USD","AMGN","LU2324357040.USD","LU2404859667.USD","BK4534","TBXU","LU2362540622.SGD","LU2362541273.HKD","LU2506951875.HKD","BK4566","IE0002141913.USD","LU0868494617.USD","XBI","GB00B4QBRK32.GBP","LU0823417653.USD","BK4588","LU0128526141.USD","IE00BJT1NW94.SGD","BK4599","LU0109394709.USD","LU0528227936.USD","BK4585","LU0029874061.USD","LU1061106388.HKD","LU2506952097.USD","LU2362541513.USD","LU2089984988.USD","BIB","HCSG","XLV","IHI","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963550","title":"Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963550","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963550?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:31","pubTimestamp":1789637460,"startTime":"0","endTime":"0","summary":"KUALA LUMPUR, Malaysia--Malaysian copper-composite manufacturer Vertex Material plans to go public in the U.S. next year after achieving a reported valuation of about $7 billion.The advanced-materials","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERX","UYM","LU0432979614.USD","VRTX","LU0256863811.USD","LU1093756168.USD","LU0889565916.HKD","IE00B894F039.SGD","LU1035775433.USD","LU1069344957.HKD","BBH","BK4139","LU0320765992.SGD","CPER","PBE","LU2468319806.SGD","BK4532","SG9999013999.USD","MHGmain","IE0009355771.USD","IE00B19Z9P08.USD","IE00B2B36J28.USD","LU0566484027.USD","LU2089984988.USD","COPJ","BIB","IE00B19Z9Z06.USD","BK4023","LU2324357040.USD","XME","QCmain","TBXU","IBB","LU2362541513.USD","IBBQ","IE0002270589.USD","LU0823416689.USD","COPP","CPXR","LU1778281490.HKD","IDNA","GNMX","LU2236285917.USD","LU1430594728.SGD","IE00BFTCPJ56.SGD","LU2417539215.USD","LU1093756325.SGD","ICOP","LU2237438978.USD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668593306","title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2668593306","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668593306?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:28","pubTimestamp":1789590524,"startTime":"0","endTime":"0","summary":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier sells USD 431,819 of common stockGilead: Chief Comm & Corp Aff Officer Johanna Mercier sold 3,000 common shares on Sep. 15, 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL6sfPNq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509283.SGD","BBH","IE00B3T34201.USD","LU1585245621.USD","MEDI","TMED","SG9999015945.SGD","BK4588","LU0114720955.EUR","SG9999015952.SGD","GILD","LU1778281490.HKD","LU1674673428.USD","IE00BZ1G4Q59.USD","IE00B19Z3581.USD","LU0823416689.USD","IE00BKVL7J92.USD","LU1066051498.USD","LU2468319806.SGD","LU0965509101.SGD","LU0109394709.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0859254822.USD","LU0882574055.USD","LU1674673691.USD","IBB","LU1430594728.SGD","BK4566","BK4585","TBXU","LU1057294990.SGD","BK4532","LU0122379950.USD","IBBQ","LU2089984988.USD","BK4550","LU0234570918.USD","BK4568","IE00BSNM7G36.USD","LU2357627491.SGD","BK4578","LU1066053197.SGD","LU2087621335.USD","LU0320765992.SGD","BMED","LU1023059063.AUD","SG9999015986.USD","LU0289739699.SGD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667983112","title":"Gilead - Expands Six Royalty-Free Voluntary Licensing Agreements for Once-Yearly Lenacapavir for Hiv Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2667983112","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667983112?lang=en_us&edition=fundamental","pubTime":"2026-09-16 20:30","pubTimestamp":1789561801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUA4XXCG2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TMED","SG9999015945.SGD","LU0965509101.SGD","BIB","IE00B7SZLL34.SGD","LU1839511570.USD","LU0823416689.USD","BK4550","LU0882574055.USD","LU0114720955.EUR","LU0122379950.USD","LU0861579265.USD","TBXU","LU0234570918.USD","LU2089984988.USD","LU1430594728.SGD","BK4566","LU2112291526.USD","LU0058720904.USD","LU1585245621.USD","LU0965509283.SGD","LU1057294990.SGD","LU1066053197.SGD","BMED","BBH","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU2324357040.USD","IBBQ","LU0965509010.AUD","BK4568","LU2087621335.USD","SG9999015978.USD","LU1037948897.HKD","LU0109394709.USD","MEDI","IE00B19Z3581.USD","IE00BKVL7J92.USD","LU2357627491.SGD","IBB","LU1037948541.HKD","LU1934455277.USD","LU0859254822.USD","GILD","LU1023059063.AUD","SG9999015952.SGD","LU1934455863.HKD","IE00BSNM7G36.USD","LU1571399168.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667979600","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667979600","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667979600?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:20","pubTimestamp":1789557614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-ascendis-pharma-asnd-and-charles-river-labs-crl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-ascendis-pharma-asnd-and-charles-river-labs-crl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","LU2324357040.USD","LU0061475181.USD","LU2417539215.USD","ASND","XLV","VRTX","BBH","LU2462157665.USD","LU1585245621.USD","VERX","LU2362541273.HKD","MEDI","IE00B894F039.SGD","LU1093756168.USD","BK4588","LU1035775433.USD","LU1093756325.SGD","LABU","SGXZ57979304.SGD","LU1778281490.HKD","LU1674673428.USD","CRL","IE00BZ9MQY76.HKD","LU2236285917.USD","LU0757428866.USD","LU0109394709.USD","BK4533","IBB","LU1430594728.SGD","LU2237438978.USD","XBI","BK4585","TBXU","LU0390134368.USD","IBBQ","IDNA","LU0029874061.USD","LU1069344957.HKD","LU0889565916.HKD","HCSG","IE00BJJMRZ35.SGD","LU1559883803.SGD","PBE","BK4023","LU2362540622.SGD","GNMX","BK4581","LU0289739699.SGD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667600950","title":"The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=2667600950","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667600950?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:20","pubTimestamp":1789557600,"startTime":"0","endTime":"0","summary":"T. Rowe Price manager looks for trouble to find his global value betsT.Rowe Price manager Sebastien Mallet is betting on more than technology for his five-star fund.One secret to global value manager Sebastien Mallet's success?","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006306889.USD","LU0267386448.USD","LU1236620834.HKD","LU2361044865.SGD","LU0683600562.USD","LU1064131342.USD","LU0122379950.USD","GDX","BK4575","IE000WAW04H5.SGD","LU1951198990.SGD","AMDG","ARTY","LU0127658192.USD","LU0868494708.USD","LU0210536198.USD","LU2417539215.USD","LU0823421333.USD","LU0868494617.USD","BK4568","SIL","LU0198837287.USD","LU2237443465.HKD","LU1668664300.SGD","LU2054465674.USD","LU0823416689.USD","LU0882574055.USD","LU0689472784.USD","LU0965509010.AUD","LU2168563687.JPY","LU2357305700.SGD","LU0787776722.HKD","IE00BYXW3230.USD","LU2756315318.SGD","LU0823397103.USD","LU1989764748.USD","AMUU","LU0133085943.USD","IETC","SKHZ","LU0106831901.USD","LU2860962120.EUR","LU1934455277.USD","SG9999004303.SGD","LU1267930813.SGD","IE00B775SV38.USD","LU0612318971.USD","AZNH","LU1267930573.SGD","IE0001KFT4U8.USD","LU1150488218.USD","LU2471134879.HKD","LU0114720955.EUR","SKUU","LU0820562030.AUD","LU1366333091.USD","LU2360107168.USD","LU0979878070.USD","AMDD","LU0070302665.USD","LU0208291251.USD","FNCL","SKHN","LU0820561818.USD","XLF","FTXO","HYNX","LU0345770993.USD","LU1303367103.USD","BK4566","IE0034235188.USD","LU0203347892.USD","LU0823421416.USD","AMDY","TROW","LU1670628061.USD","UYG","LU2168564065.EUR","LU1974910355.USD","LU0965508806.USD","LU2098885051.SGD","BK4534","LU1119994496.HKD","LU1496350171.SGD","IBB","LU0029864427.USD","SGXZ99366536.SGD","IE00BLSP4239.USD","LU2756315664.SGD","LU1989772923.USD","GILD","SMHX","LU2896262040.SGD","LU1267930490.SGD","LU2324357040.USD","LU1116320737.USD","DRIV","SKHQ","LU0353189680.USD","LU0048584097.USD","LINT","IE00BJLML261.HKD","IE00BLSP4452.SGD","LU0310799852.SGD","IE00BHPRN162.USD","IE000MB6IJN5.SGD","INTW","BK4561","LU2148611432.USD","BK4602","LU0211331839.USD","LU0234570918.USD","LU1261432733.SGD","LU1861558580.USD","LU1674673691.USD","LU1880398471.USD","LU2290526834.HKD","LU0265550359.USD","LU2247934214.USD","LU0106261372.USD","SLVR","LU2008162690.USD","LU1066051498.USD","LU0321505868.SGD","LU1923623000.USD","SKHX","LU1116320901.HKD","LU0234572021.USD","LU0203345920.USD","LU0149725797.USD","LU2237443622.USD","LU1236620750.USD","LU0128525929.USD","LU2505996681.GBP","LU0976567544.SGD","IBBQ","SGXZ51526630.SGD","LU2089985449.USD","LU0823397285.USD","LU1366192091.USD","SKHYV","LU0859254822.USD","AWAY","LU0157215616.USD","LU0786609619.USD","LU0320765646.SGD","IE000SO60NU8.SGD","BK4232","LU0823413660.USD","IE00BN8TJ469.HKD","LU2237443549.SGD","LU2023250843.SGD","LU0187121727.USD","LU0345774391.USD","LU2458330169.SGD","LU1934455194.USD","LU2097829019.USD","IE00BK4W5M84.HKD","LU1150488135.SGD","LU2355687059.USD","SKHA","FAI","LU0081259029.USD","IE00BKVL7J92.USD","LU2552382132.HKD","LU1989772840.SGD","IE000M9KFDE8.USD","LU2360106780.USD","LU1316542783.SGD","LU2168564495.EUR","LU0557290698.USD","BIB","BK4527","TMED","LU1861215975.USD","IE000F7OJYX1.SGD","MEDI","LU0943347566.SGD","WPM","FNV","LU2237443978.SGD","BK4578","LU2720916845.USD","QQQA","LU0251131958.USD","LU2764263203.CNY","IXG","USXF","LU0965509101.SGD","SKDD","SG9999002224.SGD","LU1839511570.USD","ILDR","LU2357627491.SGD","BK4142","IE00BBT3K403.USD","IE0002270589.USD","LU2236285917.USD","TBXU","WISE","BK4515","LU0056508442.USD","LU0889566641.SGD","BK4548","LU0823434740.USD","LU1914381329.SGD","LU1988902786.USD","IE00B5949003.HKD","LU2552382058.USD","JPM","HK0000304805.HKD","INYY","HK0000304797.USD","LU0174119429.USD","IE00BKDWB100.SGD","LU1043141123.HKD","BK4007","LU2361045086.USD","LU1861220033.SGD","LU0792757196.USD","LU0640476718.USD","LU0323591593.USD","LU0109394709.USD","LU0345770308.USD","LU2764263039.SGD","LU1280957306.USD","LU1244550577.SGD","XNTK","LU1032466523.USD","SG9999015945.SGD","SG9999001440.SGD","BK4520","IE00BZ1G4Q59.USD","CHAT","SAMD0main","LU0211328371.USD","LU2471134952.CNY","IE00BMPRXQ63.HKD","GOAU","IE00BJTD4V19.USD","LU0109392836.USD","LU0211327993.USD","LU2552382215.SGD","LU1430594728.SGD","SG9999015986.USD","BKNG","LU2211815571.USD","IE00B1BXHZ80.USD","TEK","LU0708994859.HKD","LU2237443895.HKD","LU0251132253.USD","LU1880398554.USD","AIQ","BBH","TRUF","LU0612318385.USD","IE0000B7K699.USD","LU0820561909.HKD","SG9999001424.SGD","LU1670627923.USD","KBWB","LU0964807845.USD","LU2468319806.SGD","LU2471134796.USD","TRFK","LU2931357623.SGD","LU2456880835.USD","LU0215105999.USD","LU2237957811.SGD","BK4504","BK4614","AMD","LU2430703251.USD","LU1804176565.USD","LU1244550494.USD","IE00BDCRKT87.USD","AMDW","BK4605","BK4588","IE00BDRTCR15.USD","LU0316494557.USD","LEGR","JBHT","IE0004445239.USD","LU0823413587.USD","DAMD","BK4529","BK4135","BK4017","TTEQ","IE00BK4W5L77.USD","LU1629891620.HKD","SG9999002232.USD","JPO","IE000BZT7R73.USD","IYG","LU1894683348.USD","LU2242649171.HKD","IE00BQXX3D17.EUR","AMDL","LU1551013425.SGD","LU2213496289.HKD","LU2746668974.SGD","LU0432979614.USD","LU1057294990.SGD","LU1674673428.USD","LU0882574139.USD","LU0211326839.USD","LU0154236417.USD","SGXZ81514606.USD","LU0496365809.HKD","BK4567","LU1061106388.HKD","LU1720051017.SGD","LU2543165471.USD","LU1043141396.HKD","BK4612","LU0077335932.USD","LU0390134368.USD","LU0942090050.USD","BK4554","BKNU","IE00B5TLWC47.USD","LU1145028129.USD","LU2471134523.USD","LU0823434583.USD","IE00BSNM7G36.USD","SK","LU0274383776.USD","LU1066053197.SGD","SOXX","LU2430703178.SGD","LU0320765992.SGD","IE0034235295.USD","LU1023059063.AUD","LU2244417387.USD","VFH","LU0058720904.USD","IE00B1XK9C88.USD","JPMO","LU2430703095.HKD","LU0345769128.USD","AUAU","AZN","LU1585245621.USD","LU2750360641.GBP","LU1496350502.SGD","GLDN","LU1037948897.HKD","LU1989764664.SGD","BK4573","AMDS","BK4581","LU2112291526.USD","IE00BMPRXR70.SGD","TFNS","SKHL","LU0225283273.USD","IE0034235303.USD","LU0353189763.USD","LU0211326755.USD","BK4139","LU1242518931.SGD","LU2381873111.SGD","LU1829250122.USD","LU2108987350.USD","GAMR","WUGI","LU1956131251.USD","LU1121112475.USD","LU1162221912.USD","FTXL","LU2505996509.AUD","LU0654597011.USD","LU1720051108.HKD","BMED","IE00B19Z3581.USD","SMH","LU2764262908.HKD","LU1363072403.SGD","LU2461242641.AUD","PSI","LU1084165304.USD","LU2106854487.HKD","IE00BWXC8680.SGD","LU0321505439.SGD","IE0009356076.USD","LU2750360997.AUD","FMTL","LU0417517546.SGD","LU1037948541.HKD","INT","07709","LU1430597077.USD","SILJ","LU0170899867.USD","BK4550","IE00B19Z3B42.SGD","AMDU","LU2462591350.SGD","LU2746668461.USD","04335","IE00B7SZLL34.SGD","LU0719512351.SGD","LU0861579265.USD","LU2168564149.EUR","SG9999015952.SGD","BK4512","LU0097036916.USD","LU1778281490.HKD","LU2023250330.USD","LU1242518857.USD","LU2177674079.SGD","SKHU","BK4543","LU1894683264.USD","BK4585","AMYY","LU2592432038.USD","LU1861559042.SGD","LU0048573561.USD","BK4022","LU1803068979.SGD","LU0310800379.SGD","BK4579","LU0823411888.USD","IE00BQXX3C00.GBP","LU2462157665.USD","LU1548497426.USD","BK4535","LU1232071149.USD","LU0256863902.USD","LU2168564222.USD","BK4583","CHPS","LU0265550946.USD","LU0426417589.USD","LU1244550221.USD","LU1917777945.USD","IE00BMPRXN33.USD","INTC","SOXY","BK4207","AMDC","LU2089984988.USD","LU2265009873.SGD","LU2458330243.SGD","LU0082616367.USD","LU0994945656.USD","LU2237443382.USD","SKHY","IE00BJTD4N35.SGD","LU0238689110.USD","LU0320765489.SGD","WNDR","LU0971096721.USD","LU2023250504.SGD","SINTCmain","BK4532","LU0742534661.SGD","LU0426412945.USD","SG9999015978.USD","BAI","LU1551013342.USD","LU0345769631.USD","IE00BQXX3F31.USD","LU1699723380.USD","LU1934455863.HKD","LU2087621335.USD","LU2237957902.USD","LU0965509283.SGD","LU0642271901.SGD","LU1571399168.USD","SGXZ23171101.USD","LU2087625088.SGD","BK4141","LU0889565916.HKD","BK4533","IE00B3T34201.USD","LU2361044949.HKD","LU0251142724.SGD","LU0889565833.HKD","LU0345774631.USD","IE00B3S45H60.SGD","AIS","BK4516","LU0289739699.SGD","IE00BFXG1179.USD","LU0266013472.USD","LU2264538146.SGD","CNAV","IYF","LU0256863811.USD","LU2250418816.HKD","LU1951200564.SGD","LU1852331112.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667607925","title":"Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2667607925","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667607925?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:00","pubTimestamp":1789556400,"startTime":"0","endTime":"0","summary":"Sling Therapeutics raises $123 million to advance thyroid eye disease drugSept 16 (Reuters)-Drug developer Sling Therapeutics said on Wednesday ithad raised $123 million to advance a late-stage trial ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL4N457178:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU0320765992.SGD","LU2468319806.SGD","LU1571399168.USD","BK4585","IE00BFTCPJ56.SGD","LU1023059063.AUD","BK4534","IBB","LU1057294990.SGD","BIB","IBBQ","LU2242652126.USD","LU2112291526.USD","LU1983299246.USD","AMGN","BBH","IE00B4R5TH58.HKD","LU0889565916.HKD","IE0002141913.USD","BK4599","BK4581","LU0868494617.USD","LU0122379950.USD","IE00B2B36J28.USD","TBXU","LU0058720904.USD","IE00BJJMRZ35.SGD","LU2089984988.USD","LU0109394709.USD","IE0009355771.USD","BK4139","IE00BJT1NW94.SGD","LU2242646821.SGD","VRDN","BK4533","LU1061106388.HKD","BK4588","SG9999001440.SGD","PJP","PBE","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667832674","title":"Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers","url":"https://stock-news.laohu8.com/highlight/detail?id=2667832674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667832674?lang=en_us&edition=fundamental","pubTime":"2026-09-16 11:47","pubTimestamp":1789530442,"startTime":"0","endTime":"0","summary":"Rohto starts Phase II trial of RE-01 cell therapy for refractory ischemic leg ulcersRohto began CDMO manufacturing for RE-01 cell therapy used in a Phase II investigator-led trial for refractory ische","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDLJMrSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1778281490.HKD","SG9999015978.USD","BK4550","LU2468319806.SGD","LU1066053197.SGD","IBBQ","LU0861579265.USD","LU1934455277.USD","IE00BKVL7J92.USD","LU0122379950.USD","LU1934455863.HKD","LU2087621335.USD","BK4578","LU1839511570.USD","LU2089984988.USD","LU1057294990.SGD","SG9999015945.SGD","LU1674673691.USD","TBXU","BIB","LU1037948541.HKD","LU0320765992.SGD","MEDI","LU1066051498.USD","LU0058720904.USD","LU1585245621.USD","BK4568","BK4532","BBH","IBB","LU0889565916.HKD","LU1430594728.SGD","LU2357627491.SGD","LU1037948897.HKD","GILD","LU1934455194.USD","TMED","BK4583","IE00B7SZLL34.SGD","LU1061106388.HKD","LU0289739699.SGD","LU0965509010.AUD","LU0823416689.USD","SG9999015986.USD","LU0965509283.SGD","IE00BZ1G4Q59.USD","BMED","LU2112291526.USD","LU0234570918.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667624218","title":"Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar","url":"https://stock-news.laohu8.com/highlight/detail?id=2667624218","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667624218?lang=en_us&edition=fundamental","pubTime":"2026-09-16 04:25","pubTimestamp":1789503924,"startTime":"0","endTime":"0","summary":"UPDATE 1-Bristol Myers sues Amgen over proposed Opdivo biosimilarSept 15 (Reuters)-Bristol Myers SquibbBMY.Nand Ono Pharmaceutical4528.Thave sued AmgenAMGN.Oin Delaware federal court, seeking to block","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL6N457192:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","IE0009355771.USD","IE00B2B36J28.USD","BMY","LU0109394709.USD","LU1236620834.HKD","LU0122379950.USD","LU0267386448.USD","LU1032466523.USD","LU1868836591.USD","IBB","LU2360032135.SGD","BK4585","SG9999001440.SGD","04332","BK4139","IBBQ","BK4532","IE00BJT1NW94.SGD","LU0225284248.USD","LU2596442595.SGD","IE00B4R5TH58.HKD","BK4581","LU1323610961.USD","LU2125154935.USD","LU1291159041.SGD","LU0889565916.HKD","PJP","LU1868837136.USD","LU1983299246.USD","LU1093756325.SGD","BK4533","LU0289739699.SGD","LU0225771236.USD","LU1571399168.USD","LU1670711040.USD","LU1430594728.SGD","LU0320765992.SGD","BIB","LU1061106388.HKD","IE00BFTCPJ56.SGD","LU1868836914.USD","LU0306807586.USD","LU0456855351.SGD","BK4566","LU0096364046.USD","BK4599","BK4534","LU2112291526.USD","BK4588","BK4007","LU1074936037.SGD","TBXU","LU1670710661.SGD","LU0321505868.SGD","LU0985481810.HKD","LU1883839398.USD","AMGN","LU1868836757.USD","LU0321505439.SGD","LU2468319806.SGD","LU0882574055.USD","LU2089984988.USD","LU2242652126.USD","BK4559","LU1093756168.USD","LU2133065610.SGD","LU0114720955.EUR","LU0058720904.USD","BBH","LU1261432733.SGD","LU0868494617.USD","LU0061475181.USD","LU1057294990.SGD","LU1989771016.USD","LU1236620750.USD","IE00BSNM7G36.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU1718418525.SGD","LU1670710588.SGD","PBE","LU2125154778.USD","LU1670711123.USD","IE00BFXG1179.USD","LU1585245621.USD","LU0306806265.USD","LU0237698245.USD","LU0432979614.USD","LU1868837300.USD","LU1023059063.AUD","IHE","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667621483","title":"Revolution Medicines gets orphan designation for pancreatic cancer treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2667621483","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667621483?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:00","pubTimestamp":1789498813,"startTime":"0","endTime":"0","summary":"The FDA granted Revolution Medicines (RVMD)’ zoldonrasib orphan designation as a treatment of pancreatic cancer. Published first on TheFly – the ul...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-gets-orphan-designation-for-pancreatic-cancer-treatment-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-gets-orphan-designation-for-pancreatic-cancer-treatment-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","IE0009354923.USD","RVMD","IE0002141913.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","IDNA","BBH","LU0109394709.USD","LABU","IE00B2B36J28.USD","BK4585","IE00BJJMRZ35.SGD","BK4588","CANC","IE00BFTCPJ56.SGD","BK4139","IE00B4R5TH58.HKD","PTH","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667490625","title":"Gilead Sciences Expands Lenacapavir Access to 14 Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2667490625","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667490625?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:43","pubTimestamp":1789487029,"startTime":"0","endTime":"0","summary":"Gilead Sciences  said Tuesday it entered into an agreement with the Pan American Health Organization to expand access to twice-yearly lenacapavir as pre-exposure prophylaxis for HIV prevention.The agreement creates a new access pathway for 14 PAHO member states in Latin America and the Caribbean outside existing voluntary licensing agreements, complementing generic access efforts across the region, the company said.The countries are Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Mexico, Panama, Paraguay, Peru, Uruguay and Venezuela, Gilead said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1571399168.USD","TBXU","IE00BZ1G4Q59.USD","LU1037948541.HKD","LU1061106388.HKD","TMED","LU1934455277.USD","LU2324357040.USD","IE00B3T34201.USD","IE00BKVL7J92.USD","LU0234570918.USD","LU1037948897.HKD","LU1778281490.HKD","LU1674673428.USD","LU0122379950.USD","LU0114720955.EUR","LU1674673691.USD","SG9999015952.SGD","BK4550","LU0861579265.USD","GILD","LU1430594728.SGD","LU1023059063.AUD","BK4588","IBBQ","LU2112291526.USD","LU0965509283.SGD","IE00B19Z3B42.SGD","LU0320765992.SGD","LU0058720904.USD","LU0965509010.AUD","BMED","BIB","BK4568","BK4566","LU0109394709.USD","IE0002270589.USD","MEDI","BBH","LU1934455863.HKD","LU0882574055.USD","LU0823416689.USD","LU0965508806.USD","LU1839511570.USD","SG9999015986.USD","IE00B19Z3581.USD","BK4585","IBB","IE00B7SZLL34.SGD","LU0859254822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667625575","title":"Gilead announces agreement with PAHO for lenacapavir access","url":"https://stock-news.laohu8.com/highlight/detail?id=2667625575","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667625575?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:15","pubTimestamp":1789485318,"startTime":"0","endTime":"0","summary":"Gilead (GILD) Sciences announced a new agreement with the Pan American Health Organization, or PAHO, to accelerate access to twice-yearly lenacapav...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-announces-agreement-with-paho-for-lenacapavir-access-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-announces-agreement-with-paho-for-lenacapavir-access-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0861579265.USD","LU1066053197.SGD","LU2324357040.USD","IE00B7SZLL34.SGD","LU0234570918.USD","LU0859254822.USD","LU0058720904.USD","LU1934455863.HKD","BK4585","LU1430594728.SGD","LU1037948897.HKD","IE00B3T34201.USD","BK4568","BK4588","LU1061106388.HKD","LU0965509101.SGD","LU2468319806.SGD","TBXU","LU1023059063.AUD","LU1778281490.HKD","IE0002270589.USD","LU1066051498.USD","GILD","LU2089984988.USD","SG9999015952.SGD","SG9999015986.USD","BIB","IBB","LU0965509010.AUD","BK4578","LU0965509283.SGD","LU1571399168.USD","LU1037948541.HKD","BK4566","IBBQ","LU1674673691.USD","BK4550","TMED","LU0289739699.SGD","LU0114720955.EUR","LU0882574055.USD","LU1585245621.USD","LU1839511570.USD","LU1674673428.USD","MEDI","BMED","BK4583","BBH","BK4532","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623063","title":"Gilead: Explores Opportunities with Brazilian Health Ministry to Advance Ministry’s Goal of Enabling Local Production of Lenacapavir","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623063","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623063?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1571399168.USD","TBXU","LU1037948541.HKD","LU1061106388.HKD","LU2468319806.SGD","LU1934455277.USD","TMED","LU2324357040.USD","IE00B3T34201.USD","IE00BKVL7J92.USD","LU0234570918.USD","LU1057294990.SGD","LU1037948897.HKD","IE00BSNM7G36.USD","LU1778281490.HKD","LU0889565916.HKD","LU1674673691.USD","SG9999015952.SGD","LU0861579265.USD","GILD","LU1430594728.SGD","BK4532","IBBQ","LU0965509283.SGD","IE00B19Z3B42.SGD","LU0965509010.AUD","LU0058720904.USD","LU2089984988.USD","BMED","BIB","LU2357627491.SGD","BK4566","SG9999015945.SGD","BK4583","LU0109394709.USD","IE0002270589.USD","SG9999015978.USD","LU1585245621.USD","MEDI","BK4578","BBH","LU0882574055.USD","LU0823416689.USD","LU1839511570.USD","SG9999015986.USD","LU1066053197.SGD","IE00B19Z3581.USD","IBB","IE00B7SZLL34.SGD","LU0859254822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623061","title":"Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623061","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623061?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDI","LU2468319806.SGD","IE00B3T34201.USD","BBH","LU1778281490.HKD","LU0965509101.SGD","IE00BKVL7J92.USD","LU1066053197.SGD","IE0002270589.USD","IE00B7SZLL34.SGD","IBBQ","LU0965509283.SGD","LU1037948897.HKD","BK4566","LU0965508806.USD","LU1066051498.USD","LU1037948541.HKD","BMED","IBB","IE00BZ1G4Q59.USD","LU1061106388.HKD","LU0109394709.USD","BK4139","BK4585","BK4532","LU1571399168.USD","LU0859254822.USD","LU1057294990.SGD","LU2089984988.USD","LU0058720904.USD","LU1934455277.USD","IE00BSNM7G36.USD","LU0965509010.AUD","LU0114720955.EUR","SG9999015945.SGD","SG9999015952.SGD","BK4578","LU2324357040.USD","LU0122379950.USD","LU1934455194.USD","BK4550","SG9999015986.USD","GILD","TMED","BK4588","LU0289739699.SGD","TBXU","BIB","BK4568","LU2357627491.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667237756","title":"Gilead: Co & Paho Announce Partnership to Accelerate Access to Twice-Yearly Lenacapavir for Hiv Prevention Across Latin America & Caribbean","url":"https://stock-news.laohu8.com/highlight/detail?id=2667237756","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667237756?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BMED","IE00B19Z3B42.SGD","LU0058720904.USD","LU1585245621.USD","LU2468319806.SGD","BK4578","IBBQ","LU2089984988.USD","BK4583","TMED","GILD","LU0965508806.USD","BIB","MEDI","BK4550","LU1057294990.SGD","LU0861579265.USD","LU0965509283.SGD","LU1674673428.USD","LU1934455277.USD","LU1066053197.SGD","BK4585","SG9999015986.USD","LU0965509101.SGD","BK4532","SG9999015945.SGD","LU1778281490.HKD","LU1061106388.HKD","LU0289739699.SGD","BBH","LU2357627491.SGD","TBXU","LU0859254822.USD","IBB","IE00B19Z3581.USD","IE0002270589.USD","LU0109394709.USD","LU1037948541.HKD","LU1839511570.USD","IE00BKVL7J92.USD","LU0882574055.USD","BK4588","LU1674673691.USD","BK4568","LU1934455194.USD","BK4566","SG9999015952.SGD","LU0320765992.SGD","IE00BZ1G4Q59.USD","SG9999015978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667230916","title":"Gilead, PAHO Agree on HIV Prevention Drug Access in Latin America, Caribbean","url":"https://stock-news.laohu8.com/highlight/detail?id=2667230916","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667230916?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":"Gilead, PAHO agree on HIV prevention drug access in Latin America, CaribbeanSept 15 (Reuters)-U.S. drugmaker Gilead SciencesGILD.Osaid on Tuesday it had reached an agreement with the Pan American Heal","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4N4570X0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU0889565916.HKD","BMED","GILD","IE00B19Z3581.USD","BK4568","IE0002270589.USD","BBH","BIB","LU1037948897.HKD","IE00BKVL7J92.USD","LU2357627491.SGD","LU0823416689.USD","SG9999015986.USD","BK4578","IE00BZ1G4Q59.USD","LU1571399168.USD","LU1674673691.USD","LU2089984988.USD","SG9999015978.USD","TMED","LU0965509010.AUD","LU1430594728.SGD","MEDI","IE00B7SZLL34.SGD","LU0320765992.SGD","LU1674673428.USD","BK4585","SG9999015945.SGD","BK4583","LU0109394709.USD","LU1023059063.AUD","LU1839511570.USD","LU1037948541.HKD","BK4532","LU0122379950.USD","LU1061106388.HKD","LU0114720955.EUR","LU1934455863.HKD","LU0289739699.SGD","IBBQ","LU0234570918.USD","BK4139","BK4566","IE00BSNM7G36.USD","LU1066053197.SGD","LU2112291526.USD","TBXU","LU1778281490.HKD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667230686","title":"Gilead: to Continue Exploring Opportunities to Work with Paho to Support Country Readiness & Scale-up of Long-Acting Hiv Prevention Access","url":"https://stock-news.laohu8.com/highlight/detail?id=2667230686","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667230686?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TBXU","TMED","BBH","IBBQ","BK4585","LU1061106388.HKD","LU0058720904.USD","LU1037948897.HKD","LU1066051498.USD","LU1674673691.USD","BK4583","LU2468319806.SGD","LU2324357040.USD","LU0861579265.USD","LU2089984988.USD","BK4532","IE00B7SZLL34.SGD","LU0859254822.USD","LU1839511570.USD","BK4588","LU1585245621.USD","GILD","IE0002270589.USD","SG9999015945.SGD","BIB","BMED","LU0289739699.SGD","IBB","LU1571399168.USD","BK4578","LU0114720955.EUR","LU1037948541.HKD","MEDI","LU1934455863.HKD","LU0882574055.USD","BK4566","LU0965509283.SGD","LU1023059063.AUD","LU1430594728.SGD","SG9999015952.SGD","BK4568","LU0234570918.USD","LU1674673428.USD","LU0965509010.AUD","IE00B3T34201.USD","SG9999015986.USD","LU0965509101.SGD","LU1066053197.SGD","BK4550","LU1778281490.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623244","title":"Gilead Exec Says Weekly Oral Hiv Prevention Drug Expected to Launch in First Quarter of 2027 - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623244","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623244?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:04","pubTimestamp":1789484692,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570NU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBBQ","BK4566","LU1037948541.HKD","LU1839511570.USD","MEDI","LU0289739699.SGD","BIB","LU0320765992.SGD","BK4568","LU0965509101.SGD","LU0114720955.EUR","LU0122379950.USD","BMED","LU1585245621.USD","IE00B7SZLL34.SGD","LU0965509283.SGD","BK4532","BK4550","LU0234570918.USD","LU0859254822.USD","LU1674673428.USD","LU1674673691.USD","SG9999015978.USD","TMED","LU1934455277.USD","LU0965509010.AUD","LU0882574055.USD","SG9999015952.SGD","IBB","SG9999015945.SGD","TBXU","LU1037948897.HKD","BK4139","GILD","LU1066053197.SGD","IE0002270589.USD","IE00B19Z3581.USD","LU1430594728.SGD","LU2112291526.USD","BK4588","LU0889565916.HKD","LU2324357040.USD","LU1061106388.HKD","LU0058720904.USD","LU1066051498.USD","BBH","LU1934455863.HKD","IE00BKVL7J92.USD","LU1057294990.SGD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667462372","title":"Gilead Exec Says Hiv Market Growth Should Normalize to 2%-3% Within Next Couple of Quarters - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2667462372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667462372?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:04","pubTimestamp":1789484692,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570NU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0114720955.EUR","IBBQ","LU1674673691.USD","LU0109394709.USD","IE00B3T34201.USD","TMED","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU0859254822.USD","LU1585245621.USD","BIB","LU0234570918.USD","LU0882574055.USD","BBH","SG9999015978.USD","LU0965509101.SGD","LU2089984988.USD","IBB","LU1061106388.HKD","BK4550","LU1934455277.USD","LU1934455863.HKD","LU0965508806.USD","LU1571399168.USD","IE00B19Z3B42.SGD","LU1037948541.HKD","MEDI","LU0965509010.AUD","LU1674673428.USD","LU0122379950.USD","LU2324357040.USD","LU0289739699.SGD","LU1057294990.SGD","LU2357627491.SGD","LU1430594728.SGD","IE00BSNM7G36.USD","BK4568","BK4532","BMED","BK4578","LU2112291526.USD","SG9999015945.SGD","GILD","LU1023059063.AUD","TBXU","LU0823416689.USD","LU0889565916.HKD","BK4139","LU1934455194.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}